← Back to patent-cliff list
CAS 1824712-63-1
Benzyl L-prolyl-D-alaninate hydrochloride
Codes: (XVI)692039-1-b
Application context (from source-drug indications)
冠状病毒感染TRV-120027COVID-19TRV-120027Acute decompensated heart failureTRV-120027Kidney diseaseTRV-120027Heart failureTRV-120027
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| TRV-120027 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Benzyl L-histidyl-L-prolyl-D-alaninate hydrochloride→N-[(Benzyloxy)carbonyl]-N-methylglycyl-L-arginine→(2S)-1-[(2-Methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid→Ethoxycarbonyl 1-(tert-butoxycarbonyl)-L-prolinate→2-{[(Benzyloxy)carbonyl](methyl)amino}acetic acid→Benzyl D-alaninate 4-methylbenzenesulfonate→Benzyl L-prolyl-D-alaninate hydrochloride→(2S)-2-{[(tert-Butoxy)carbonyl]amino}-3-(1H-imidazol-5-yl)propanoic acid→Benzyl N-(tert-butoxycarbonyl)-L-histidyl-L-prolyl-D-alaninate→Pentafluorophenyl trifluoroacetate→Pentafluorophenyl N-[(benzyloxy)carbonyl]-N-methylglycinate→(S)-(+)-Arginine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.